Advancing the Regulation of Traditional and Complementary Medicine Products: A Comparison of Five Regulatory Systems on Traditional Medicines with a Long History of Use

Abstract

Background. An appropriate regulatory system to ensure and promote the quality, safety, and efficacy of the products of traditional medicine (TM) and complementary medicine (CM) is critical to not only public health but also economic growth. The regulatory approach and evaluation standards for TM/CM products featured with a long history of use are yet to be developed. This study aims to investigate and compare the existing regulatory approaches for TM/CM products with a long history of use. Method. A mixed approach of documentary analysis involving official and legal documents from official websites, as well as a scoping review of scholarly work in scientific databases about regulatory systems of TM/CM products in China, Hong Kong, Taiwan, Japan, and Korea, was employed in this study and used for comparison. Results. For registration purposes, all five regulatory systems recognized the history of use as part of the totality of evidence when evaluating the safety and efficacy of TM/CM products with a long history of use. Generally, the list of classic formulas is predefined and bound to the formulas recommended in the prescribed list of ancient medical textbooks. Expedited pathways are usually in place and scientific data of nonclinical and clinical studies may be exempted. At the same time, additional restrictions with the scope of products constitute a comprehensive approach in the regulation. Quality assurance and postmarketing safety surveillance were found to be the major focus across the regulatory schemes investigated in this study. Conclusion. The regulatory systems investigated in this study allow less stringent registration requirements for TM/CM products featured with a long history of use, assuming safety and efficacy to be plausible based on historic use. Considering the safety and efficacy of these products, regulatory standards should emphasize the technical requirements for quality control and postmarket surveillance.

A model of purchase intention of complementary and alternative medicines: the role of social media influencers’ endorsements

“…Legislation around CAM use differs across different countries; where some countries regulate the manufacturing, distribution, and sale of CAMs like pharmaceutical products [ 109 ], but most governments do not regulate CAMs as medical or health products [ 110 ]. This lack of regulation allows manufacturers of CAMs to promote their products without a scientific check on the promotional content [ 111 ].…”

A Comparative View on the Traditional and Complementary Medicine (TCM) Regulation in Malaysia and China

“…(Hu, 2021). In China, the need for clinical safety data may be exempted from "classic Chinese medicine formulas" which have been used in clinical practice for hundreds or thousands of years (Liang et. al, 2021).…”

“…Traditional and Complementary Medicine (TCM) is found in almost every country, and the demand for its services is increasing. It refers to theories, beliefs, knowledge, abilities, and practices founded on them based on experiences unique to various civilisations (Zakaria, 2021;Liang et al, 2021;Kim, 2017). The Malaysian Ministry of Health's Division of Traditional and Complementary Medicine describes the therapeutic notion as healing in the form of medicine or therapy that can aid in treating an illness or disability.…”

Cytotoxic Activity of Herbal Medicines as Assessed in Vitro: A Review

“…Every year, studies expand on the chemical composition and properties of herbal medicines to assess the various interactions and molecular mechanisms which are associated with use of crude extracts, essential oils or compounds. [63][64][65] The main objectives of cytotoxicity and cell viability assays are to assess any potential of anticancer agents, and evaluate the deleterious side effects associated with herbal medicines which damage normal cells and organisms. [34,35] The cell-based cytotoxicity assays are widely used and Table 1.…”